June 15, 2015
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Imprimis reports $1.6 million in revenue in first quarter
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Imprimis Pharmaceuticals reported total revenue of $1.6 million in the first quarter of 2015 compared with $2,000 in the first quarter of the previous year, according to a press release.
Net loss was reported at $3.1 million, or $0.33 per common share, in the first quarter compared with a net loss of $2.3 million, or $0.26 per common share, in the first quarter of 2014.
General and administrative expenses were reported at $2.5 million in the first quarter compared with $1.9 million a year ago. Selling and marketing expenses were reported at $1 million in the first quarter compared with $382,000 in the first quarter of the previous year.